Keene & Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.59M Sell
35,464
-22,980
-39% -$1.09M 1.27% 31
2024
Q3
$2.81M Buy
58,444
+1,803
+3% +$86.9K 2.13% 28
2024
Q2
$2.88M Buy
56,641
+216
+0.4% +$11.8K 2.35% 26
2024
Q1
$3.06M Buy
56,425
+7,730
+16% +$403K 2.29% 29
2023
Q4
$2.74M Sell
48,695
-1,080
-2% -$61K 2.28% 27
2023
Q3
$3.07M Buy
+49,775
New +$3.15M 2.47% 16

Other funds holding NTR

Keene & Associates's NTR Position: Q4 2024 in Review

Keene & Associates reduced its Nutrien (NTR) stake by 39% in Q4 2024, selling an estimated $1.09M and leaving 35,464 shares worth $1.59M. The position accounts for 1.27% of the portfolio, ranked #31.

Keene & Associates first reported a position in NTR in Q3 2023 and has held it in 6 quarters since. The position peaked at $3.07M in Q3 2023. 591 funds tracked by Wall St. Rank hold NTR as of Q4 2024.

  • Keene & Associates held 35,464 shares of Nutrien worth $1.59M as of Q4 2024.
  • Keene & Associates sold 22,980 Nutrien shares in Q4 2024, an estimated $1.09M.
  • Nutrien made up 1.27% of Keene & Associates's portfolio in Q4 2024, its #31 holding.
  • Keene & Associates first reported a position in Nutrien in Q3 2023 and has held it in 6 quarters since.
  • Keene & Associates's Nutrien position peaked at $3.07M in Q3 2023.
  • 591 funds tracked by Wall St. Rank held Nutrien as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.